Altos Labs
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Altos Labs, United States, covering academic research published from 2020 to 2024. Read More.
Open Access Percentage
79%
Total
Publications
274
Total Open
Publications
217
Total
Citations
6.4K
Open Access
Percentage
79%
Total
Publications
274
Total Open
Publications
217
Total
Citations
6.4K
Breakdown
Publisher Open
7%
Both
36%
Other Platform Open
35%
Closed
22%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 67%
74
Hybrid 22%
25
No Guarantees 11%
12
Other Platform Open
Domain 71%
136
Preprint 40%
76
Institution 16%
31
Other Internet 2%
3
Public 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 136 |
bioRxiv | Preprint | 70 |
Vrije Universiteit Amsterdam | Institution | 6 |
Pompeu Fabra University | Institution | 5 |
medRxiv | Preprint | 3 |
Wageningen University & Research | Institution | 2 |
University of Milan | Institution | 2 |
University of Edinburgh | Institution | 2 |
Swiss School of Archaeology in Greece | Institution | 2 |
Research Square | Preprint | 2 |